In-Silico Anti-Diarrhoeal Evaluation of Lagu Gangathara Chooranam
Keywords:Molecular docking, Lagu Gangathara Chooranam, Antidiarrhoeal activity, M3 muscarinic Acetylcholine receptor, Siddha
Background: In siddha system of medicine diarrhoea can be compared with kazhichal. Diarrhoea results from several factors like intestinal hyper-motility, malabsorbtion of water, inflammation of GIT or use of laxatives. In siddha literature, the preparation named lagu gangathara chooranam is indicated for kazhichal. Aim: The study aims to perform the in-silico computational studies of phytoconstituents of the siddha formulation lagu gangathara chooranam targeted against m3 muscarinic acetyl choline receptor for anti-diarrhoeal activity. Methods: The retrieved phytocomponents were subjected for docking calculations against target enzyme m3 muscarinic acetylcholine receptor. Results: The computational analysis retrived 11 bio-active compounds from herbal formulation. It includes limonene, α-humulene, cyperolone, lupeol, beta amyrin, betulinic acid, mangiferin, quercetin, caryophyllene and luteolin. These compounds significantly bind against the target m3 muscarinic acetylcholine receptor. Hence these phytocompounds may produce significant anti-diarrheal activity by hindering the activity of m3 muscarinic acetylcholine receptor in the intestinal region which mediates the diarrhoea. Conclusion: Further clinical trials or experimental studies could be conducted to confirm the effectiveness of this siddha formulation lagu gangathara chooranam against diarrhoea.
How to Cite
Copyright (c) 2024 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.